Abstract
Human papillomaviruses (HPV) are double-stranded DNA viruses, which selectively infect keratinocytes in stratified epithelia. After an initial infection, many patients clear HPV. In some patients, however, HPV persist, and dysfunctional innate immune responses to HPV infection could be involved in the ineffective clearing of these viruses. In this study, the mechanisms of HPV-induced immune responses in keratinocytes were investigated. Binding of viral DNA leads to AIM2 inflammasome activation and IL-1β release, while IFI16 activation results in IFN-β release. Using immunohistochemistry, AIM2 and IFI16—two recently identified sensors for cytosolic DNA—were also detected in HPV positive skin lesions. CISH stainings further confirmed the presence of cytosolic HPV16 DNA in biopsy samples. Moreover, active IL-1β and cleaved caspase-1 were detected in HPV infected skin, suggesting inflammasome activation by viral DNA. In subsequent functional studies, HPV16 DNA triggered IL-1β and IL-18 release via the AIM2 inflammasome in normal human keratinocytes. Although HPV DNA did not induce IFN-β in keratinocytes, IFN-β secretion was observed when AIM2 was blocked. Meanwhile, blocking of IFI16 increased HPV16 DNA-induced IL-1β, but not IL-18, secretion. These findings suggest crosstalk between IFI16 and AIM2 in the immune response to HPV DNA. In sum, novel aspects concerning HPV-induced innate immune responses were identified. Eventually, understanding the mechanisms of HPV-induced inflammasome activation could lead to the development of novel strategies for the prevention and treatment of HPV infections.
Similar content being viewed by others
References
Bauernfeind F, Ablasser A, Bartok E, Kim S, Schmid-Burgk J, Cavlar T, Hornung V (2011) Inflammasomes: current understanding and open questions. Cell Mol Life Sci 68(5):765–783
Burdette D, Haskett A, Presser L, McRae S, Iqbal J, Waris G (2012) Hepatitis C virus activates interleukin-1beta via caspase-1-inflammasome complex. J Gen Virol 93(2):235–246
Cavlar T, Ablasser A, Hornung V (2012) Induction of type I IFNs by intracellular DNA-sensing pathways. Immunol Cell Biol 90(5):474–482
Choubey D (2012) DNA-responsive inflammasomes and their regulators in autoimmunity. Clin Immunol 142(3):223–231
Costa S, Borgogna C, Mondini M, De Andrea M, Meroni PL, Berti E, Gariglio M, Landolfo S (2011) Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing. Br J Dermatol 164(2):282–290
Dell G, Gaston K (2001) Human papillomaviruses and their role in cervical cancer. Cell Mol Life Sci 58(12–13):1923–1942
Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550
Dombrowski Y, Peric M, Koglin S, Kammerbauer C, Goss C, Anz D, Simanski M, Glaser R, Harder J, Hornung V, Gallo RL, Ruzicka T, Besch R, Schauber J (2011) Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med 3(82):82ra38
Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, Beer HD (2007) The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 17(13):1140–1145
Franceschi S, De Vuyst H (2009) Human papillomavirus vaccines and anal carcinoma. Curr Opin HIV AIDS 4(1):57–63
George PM, Badiger R, Alazawi W, Foster GR, Mitchell JA (2012) Pharmacology and therapeutic potential of interferons. Pharmacol Ther 135(1):44–53
Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S (2012) Clifford GM (2012) Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 131(10):2349–2359
Hebner CM, Laimins LA (2006) Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol 16(2):83–97
Hertzog P, Forster S, Samarajiwa S (2011) Systems biology of interferon responses. J Interf Cytokine Res 31(1):5–11
Honda K, Takaoka A, Taniguchi T (2006) Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25(3):349–360
Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, Fitzgerald KA (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458(7237):514–518
Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A (2009) Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206(1):79–87
Karim R, Meyers C, Backendorf C, Ludigs K, Offringa R, van Ommen GJ, Melief CJ, van der Burg SH, Boer JM (2011) Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS ONE 6(3):e17848
Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, Chandran B (2011) IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe 9(5):363–375
Kim S, Bauernfeind F, Ablasser A, Hartmann G, Fitzgerald KA, Latz E, Hornung V (2010) Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome. Eur J Immunol 40(6):1545–1551
Komune N, Ichinohe T, Ito M, Yanagi Y (2011) Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1beta secretion. J Virol 85(24):13019–13026
Koromilas AE, Li S, Matlashewski G (2001) Control of interferon signalling in human papillomavirus infection. Cytokine Growth Factor Rev 12(2–3):157–170
Kreuter A, Brockmeyer NH, Weissenborn SJ, Gambichler T, Stucker M, Altmeyer P, Pfister H, Wieland U, German Competence Network HA (2008) Penile intraepithelial neoplasia is frequent in HIV-positive men with anal dysplasia. J Invest Dermatol 128(9):2316–2324
Kreuter A, Potthoff A, Brockmeyer NH, Gambichler T, Swoboda J, Stucker M, Schmitt M, Pfister H, Wieland U (2010) Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany. Br J Dermatol 162(6):1269–1277
Krieg AM (2010) AIMing 2 defend against intracellular pathogens. Nat Immunol 11(5):367–369
Lamkanfi M, Dixit VM (2011) Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol 187(2):597–602
Lechardeur D, Sohn KJ, Haardt M, Joshi PB, Monck M, Graham RW, Beatty B, Squire J, O’Brodovich H, Lukacs GL (1999) Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther 6(4):482–497
Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, Petoumenos K, Roberts J, Tabrizi SN, Templeton DJ, Grulich AE (2012) Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 13(5):487–500
Nour AM, Reichelt M, Ku CC, Ho MY, Heineman TC, Arvin AM (2011) Varicella-zoster virus infection triggers formation of an interleukin-1beta (IL-1beta)-processing inflammasome complex. J Biol Chem 286(20):17921–17933
Pagliusi S (18 July 2001) Vaccines against Human Papillomavirus. WHO. http://www.who.int/vaccines/en/hpvrd.shtml
Rathinam VA, Fitzgerald KA (2011) Innate immune sensing of DNA viruses. Virology 411(2):153–162
Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, Hornung V, Vogel SN, Szomolanyi-Tsuda E, Fitzgerald KA (2010) The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 11(5):395–402
Renne J, Schafer V, Werfel T, Wittmann M (2010) Interleukin-1 from epithelial cells fosters T cell-dependent skin inflammation. Br J Dermatol 162(6):1198–1205
Stanley M (2006) Immune responses to human papillomavirus. Vaccine 24(Suppl 1):S16–S22
Stanley M (2007) Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer. Br J Cancer 96(9):1320–1323
Stanley MA (2009) Immune responses to human papilloma viruses. Ind J Med Res 130(3):266–276
Stanley MA (2012) Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev 25(2):215–222
Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, Sirois CM, Jin T, Latz E, Xiao TS, Fitzgerald KA, Paludan SR, Bowie AG (2010) IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11(11):997–1004
Veeranki S, Duan X, Panchanathan R, Liu H, Choubey D (2011) IFI16 protein mediates the anti-inflammatory actions of the type-I interferons through suppression of activation of caspase-1 by inflammasomes. PLoS ONE 6(10):e27040
Wei W, Clarke CJ, Somers GR, Cresswell KS, Loveland KA, Trapani JA, Johnstone RW (2003) Expression of IFI 16 in epithelial cells and lymphoid tissues. Histochem Cell Biol 119(1):45–54
Acknowledgments
This study was funded by the Deutsche Forschungsgemeinschaft (Scha979/5-1), the Fritz Thyssen Stiftung and the Else Kroener Fresenius Stiftung (2012-A119).
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Reinholz, M., Kawakami, Y., Salzer, S. et al. HPV16 activates the AIM2 inflammasome in keratinocytes. Arch Dermatol Res 305, 723–732 (2013). https://doi.org/10.1007/s00403-013-1375-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-013-1375-0